Home / Tag Archives: Food and Drug Administration

Tag Archives: Food and Drug Administration

Booz Allen Lands FDA Contract for Event Reporting System Support

TYSONS CORNER, VA, October 4, 2018 — Booz Allen Hamilton (NYSE: BAH) will provide information technology services in support of a Food and Drug Administration incident tracking system under a potential $36M contract, ExecutiveBiz reported Wednesday. The agency said in a FedBizOpps notice posted Tuesday Booz Allen will provide licenses for pharmacovigilance …

Read More »

Mitre, FDA Unveil Playbook for Medical Device Cybersecurity, Preparedness

TYSONS CORNER, VA, October 3, 2018 — Mitre and the Food and Drug Administration have developed a guide that aims to help healthcare service providers establish preparedness and response measures for medical devices amid cybersecurity threats, ExecutiveBiz reported Tuesday. The nonprofit research firm said Monday the Medical Device Cybersecurity Regional Incident Preparedness …

Read More »

FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

The Food and Drug Administration has awarded four companies contracts worth up to $75M each to develop automated methods for reporting adverse drug events. IBM (NYSE: IBM), Acumen, Dovel Technologies and IQVIA Government Solutions will use artificial intelligence, machine learning, natural language processing and other automation techniques to create data collection and analysis systems …

Read More »

Four Firms to Provide Data Sources, Tools for FDA’s Biologics Surveillance Effort

Four companies have each won a potential five-year, $75M contract to provide the Food and Drug Administration’s center for biologics evaluation and research with data, tools and infrastructure for use in the surveillance of vaccines, tissues, blood products and other biologics. A FedBizOpps notice posted Monday says IBM (NYSE: IBM), …

Read More »

Booz Allen Hamilton Helps FDA Test Healthcare Blockchain Technology

TYSONS CORNER, VA, June 26, 2018 — Booz Allen Hamilton (NYSE: BAH) has helped develop and test a blockchain-based platform designed to help the Food and Drug Administration’s Office of Translational Sciences explore how to use the technology for healthcare applications, ExecutiveBiz reported Monday. The platform, which is currently implemented …

Read More »

Booz Allen, Octo Consulting Land Spots on $300M FDA Data Tech Modernization BPA

The Food and Drug Administration has awarded Booz Allen Hamilton (NYSE: BAH) and Octo Consulting Group spots on a potential seven-year, $300 million blanket purchase agreement to update data collection and analysis systems in support of FDA’s patient safety and drug development efforts, the Washington Business Journal reported Tuesday. Octo said …

Read More »

NTT Data Names Shamlan Siddiqi CTO for Public Sector Group; Tim Conway Comments

Shamlan Siddiqi, formerly vice president for digital and cloud services at NTT Data (NYSE: NTT), has assumed the role of chief technology officer for the company’s public sector business. NTT Data said Thursday Siddiqi will oversee the public sector group’s technology, advisory and innovation programs with government agencies. “Shamlan brings a …

Read More »

Potomac Officers Club Rounds Out Speakers For 2017 Healthcare Forum

TYSONS CORNER, VA., March 20, 2017 — The Potomac Officers Club — a division of Executive Mosaic — rounded out the speakers list for their 2017 Healthcare Forum to be held on March 23rd. The Healthcare Forum will present leaders in both the public and private sector discussing digital healthcare, interoperability and …

Read More »

Potomac Officers Club Presents Speakers For 2017 Healthcare Forum

TYSONS CORNER, VA., March 14, 2017 — The Potomac Officers Club — a division of Executive Mosaic — released the speakers list for their 2017 Healthcare Forum. The Healthcare Forum will present leaders in both the public and private sector discussing digital healthcare, interoperability and cybersecurity. The new era of medicine incorporates …

Read More »

CSRA’s DynPort Vaccine Company Gets Orphan Drug Designation on Plague Vaccine

TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and Drug Administration on a plague vaccine it is developing as a potential pre-exposure prophlaxis treatment against Yersinia pestis infection, ExecutiveBiz reported Thursday. The company said Wednesday the designation enables DynPort Vaccine Company to …

Read More »